| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $656.5M | +19.2% | -2.6% |
| Cost of Revenue | $325.2M | +21.8% | -8.5% |
| Gross Profit | $331.3M | +16.8% | +4.1% |
| R&D Expense | $65.0M | +4.7% | +7.8% |
| SG&A Expense | $102.9M | +2.1% | -21.6% |
| Operating Income | -$14.3M | -134.6% | +68.8% |
| Pre-tax Income | -$39.0M | -367.1% | +57.2% |
| Income Tax | -$200K | -128.6% | -128.6% |
| Net Income | -$38.8M | -379.1% | +57.8% |
| EPS (Basic) | -$0.09 | -400.0% | +62.5% |
| EPS (Diluted) | -$0.09 | -400.0% | +62.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.18B | +6.9% | +42.3% |
| Accounts Receivable | $94.6M | +34.4% | -2.3% |
| Inventory | $214.9M | -9.6% | -16.6% |
| Current Assets | $1.56B | +2.9% | +19.0% |
| Total Assets | $2.16B | -0.3% | +2.6% |
| Current Liabilities | $784.8M | -1.3% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $143.8M | +100.0% | — |
| Investing Cash Flow | -$7.6M | -13.4% | — |
| Financing Cash Flow | -$2.6M | -52.9% | — |
| +23.6% |
| Long-term Debt | $1.53B | -0.2% | -0.6% |
| Total Liabilities | $2.49B | -1.0% | -4.4% |
| Stockholders' Equity | -$326.7M | +5.9% | +34.3% |